SCHEMBL3309302

SCHEMBL3309302

CCOC(=O)c1cc2ccccc2cc1O[C@H]1CC[C@H]2C(CC)N(C(=O)OC(C)(C)C)[C@H](C(=O)O)C[C@H]2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
HPGD P15428 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
DRD2 P14416 2/20 0.34
DRD4 P21917 2/20 0.34
LMNA P02545 3/20 0.33
POLB P06746 2/20 0.33
TP53 P04637 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
GPR119 Q8TDV5 1/20 0.32
ACE P12821 3/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3305097 0.89 GRIK1 (0.41) MEN1KMT2AHPGDKDM4EALDH1A1
SCHEMBL3297263 0.89 MEN1 (0.34) MEN1KMT2AHPGDKDM4EALDH1A1
SCHEMBL3305704 0.87 GRIK1 (0.40) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL3300496 0.87 GRIK1 (0.40) MEN1KMT2AALDH1A1LMNAPOLB
SCHEMBL3303205 0.85 SMN1; SMN2 (0.35) MEN1KMT2AHPGDALDH1A1TP53
SCHEMBL3303210 0.85 SMN1; SMN2 (0.35) MEN1KMT2AHPGDALDH1A1TP53
SCHEMBL3391628 0.83 MEN1 (0.43) MEN1KMT2AHPGDKDM4EALDH1A1
SCHEMBL3303849 0.80 GPR119 (0.35) MEN1KMT2AGPR119
SCHEMBL3303406 0.78 GRIK1 (0.35) GPR119
SCHEMBL3306973 0.77 GRIK1 (0.36) MEN1KMT2AHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100094014-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS MARTINEZ-PEREZ JOSE ANTONIO 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094014-A1 EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS SLC1A2, SLC1A1, GRIN1 MEN1 1115/4885KMT2A 1887/4885HPGD 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.